SCHEMBL5501367

SCHEMBL5501367

CCCc1ncc(OC(C)=O)c(N)n1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.37
SLC19A2 O60779 1/20 0.37
USP2 O75604 1/20 0.37
LMNA P02545 1/20 0.37
CASP1 P29466 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
HSP90AA1 P07900 1/20 0.37
PDE10A Q9Y233 1/20 0.35
PTGS2 P35354 7/20 0.34
P2RX3 P56373 1/20 0.33
P2RX2 Q9UBL9 1/20 0.33
NPC1 O15118 1/20 0.33
NFKB1 P19838 1/20 0.33
RAB9A P51151 1/20 0.33
NFKB2 Q00653 1/20 0.33
RELA Q04206 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
PPARG P37231 1/20 0.33
PPARA Q07869 1/20 0.33
ADORA2A P29274 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5500327 0.83 PDE10A (0.36) KDM4ETDP1HSP90AA1PDE10APTGS2
SCHEMBL5502465 0.82 PTGS2 (0.37) KDM4ELMNATDP1HSP90AA1PDE10A
SCHEMBL28286610 0.79 P2RX3 (0.43) KDM4ESLC19A2USP2LMNACASP1
SCHEMBL4046039 0.76 LMNA (0.42) KDM4ELMNATDP1PTGS2P2RX3
SCHEMBL10684961 0.75 PTGS2 (0.38) KDM4ELMNATDP1PDE10APTGS2
SCHEMBL10760805 0.74 PTGS2 (0.40) KDM4ELMNATDP1PTGS2NPC1
SCHEMBL907573 0.69 KDM4E (0.36) KDM4ELMNACASP1TDP1PDE10A
SCHEMBL28064354 0.67 P2RX3 (0.38) KDM4ETDP1PTGS2P2RX3P2RX2
SCHEMBL10349243 0.67 LMNA (0.60) KDM4ESLC19A2USP2LMNACASP1
SCHEMBL7449061 0.66 KDM4E (0.44) KDM4EP2RX3P2RX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1005470-B1 OXINDOLYLQUINAZOLINE DERIVATIVES AS ANGIOGENESIS INHIBITORS ASTRAZENECA AB (SE) 2007-08-01 EP disclosed
US-6294532-B1 TREATMENT OF A NUMBER OF DISEASE STATES INCLUDING CANCER AND RHEUMATOID ARTHRITIS. ZENECA LIMITED (GB) 2001-09-25 US disclosed
EP-1005470-A1 OXINDOLYLQUINAZOLINE DERIVATIVES AS ANGIOGENESIS INHIBITORS ZENECA LIMITED (GB) 2000-06-07 EP disclosed
WO-1999010349-A1 OXINDOLYLQUINAZOLINE DERIVATIVES AS ANGIOGENESIS INHIBITORS ZENECA LIMITED (GB) 1999-03-04 WO disclosed